title: Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.
abstract: The major problem associated with conventional drug delivery systems is unpredictable plasma concentrations. The aim of this study was to design a controlled porosity osmotic pump (CPOP) of diltiazem hydrochloride to deliver the drug in a controlled manner. CPOP tablets were prepared by incorporation of drug in the core and subsequent coating with cellulose acetate as semi-permeable membrane. Non-ionic surfactants were applied as pore-formers as well. The effect of pore-formers concentration on the in vitro release of diltiazem was also studied. The formulations were compared based on four comparative parameters, namely, total drug released after 24 h (D24 h), lag-time (tL), squared correlation coefficient of zero order equation (RSQzero) and mean percent deviation from zero order kinetic (MPDzero). Results of scanning electron microscopy studies exhibited formation of pores in the membrane from where the drug release occurred. It was revealed that drug release rate was directly proportional to the concentration of the pore-formers. The value of D24 h in the formulations containing Tween 80 (10%) and Brij 35 (5%) were found to be more than 94.9%, and drug release followed zero order kinetic (RSQzero > 0.99 and MPDzero < 8%) with acceptable tL (lower than 1 h).
authors.affiliation: Drug Applied Research Center .
authors.forename: Khosro
authors.initials: K
authors.lastname: Adibkia
authors.forename: Saeed
authors.initials: S
authors.lastname: Ghanbarzadeh
authors.forename: Mohammad Hosein
authors.initials: MH
authors.lastname: Shokri
authors.forename: Zahra
authors.initials: Z
authors.lastname: Arami
authors.forename: Zeinab
authors.initials: Z
authors.lastname: Arash
authors.forename: Javad
authors.initials: J
authors.lastname: Shokri
mesh_terms: D002482:Cellulose / Q000031:analogs & derivatives / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations / Q000138:chemical synthesis*; D004110:Diltiazem / Q000737:chemistry*; D016503:Drug Delivery Systems / Q000379:methods; D007700:Kinetics; D009995:Osmosis; D011092:Polyethylene Glycols / Q000737:chemistry; D011136:Polysorbates / Q000737:chemistry; D016062:Porosity; D013501:Surface-Active Agents / Q000737:chemistry*; D013607:Tablets / Q000737:chemistry
chemical_list: D003692:Delayed-Action Preparations; D011136:Polysorbates; D013501:Surface-Active Agents; D013607:Tablets; C005062:acetylcellulose; D011092:Polyethylene Glycols; D002482:Cellulose; D004110:Diltiazem; C515901:Brij 35